Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
BI-3820768 in germ cell cancers: NCT07306559 Clinical Landscape Report 2026
18 September 2026
NCT07306559 clinical landscape for germ cell cancers: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
DPTX-3186 in Lung Cancer: NCT07312903 Clinical Landscape Report 2026
18 September 2026
NCT07312903 clinical landscape for Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CLR-121125 in Triple Negative Breast Cancer: NCT07311993 Clinical Landscape Report 2026
18 September 2026
NCT07311993 clinical landscape for Triple Negative Breast Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
BRY-812 in Female Genital Neoplasms: NCT07311538 Clinical Landscape Report 2026
18 September 2026
NCT07311538 clinical landscape for Female Genital Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Fluzoparib in Platinum-Sensitive Ovarian Carcinoma: NCT07321015 Clinical Landscape Report 2026
18 September 2026
NCT07321015 clinical landscape for Platinum-Sensitive Ovarian Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Medroxyprogesterone Acetate in Endometrial Carcinoma: NCT07319429 Clinical Landscape Report 2026
18 September 2026
NCT07319429 clinical landscape for Endometrial Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Fulvestrant in Metastatic Solid Tumor: NCT07318805 Clinical Landscape Report 2026
18 September 2026
NCT07318805 clinical landscape for Metastatic Solid Tumor: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Carboplatin in Mucosal Melanoma: NCT07336979 Clinical Landscape Report 2026
18 September 2026
NCT07336979 clinical landscape for Mucosal Melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Avutometinib in Endometrial Carcinoma: NCT07318324 Clinical Landscape Report 2026
18 September 2026
NCT07318324 clinical landscape for Endometrial Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Abemaciclib in Triple Negative Breast Cancer: NCT07340541 Clinical Landscape Report 2026
18 September 2026
NCT07340541 clinical landscape for Triple Negative Breast Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lenalidomide in Multiple Myeloma: NCT07341867 Clinical Landscape Report 2026
18 September 2026
NCT07341867 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Melatonin in Endometrial Carcinoma: TCTR20260113003 Clinical Landscape Report 2026
18 September 2026
TCTR20260113003 clinical landscape for Endometrial Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.